Your browser doesn't support javascript.
loading
Dietary intake of vitamin C and gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project.
Sassano, Michele; Seyyedsalehi, Monireh Sadat; Collatuzzo, Giulia; Pelucchi, Claudio; Bonzi, Rossella; Ferraroni, Monica; Palli, Domenico; Yu, Guo-Pei; Zhang, Zuo-Feng; López-Carrillo, Lizbeth; Lunet, Nuno; Morais, Samantha; Zaridze, David; Maximovich, Dmitry; Martín, Vicente; Castano-Vinyals, Gemma; Vioque, Jesús; González-Palacios, Sandra; Ward, Mary H; Malekzadeh, Reza; Pakseresht, Mohammadreza; Hernández-Ramirez, Raul Ulises; López-Cervantes, Malaquias; Negri, Eva; Turati, Federica; Rabkin, Charles S; Tsugane, Shoichiro; Hidaka, Akihisa; Lagiou, Areti; Lagiou, Pagona; Camargo, M Constanza; Curado, Maria Paula; Boccia, Stefania; La Vecchia, Carlo; Boffetta, Paolo.
Afiliação
  • Sassano M; Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
  • Seyyedsalehi MS; Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
  • Collatuzzo G; Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
  • Pelucchi C; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Bonzi R; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Ferraroni M; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Palli D; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, ISPRO, Florence, Italy.
  • Yu GP; Medical Informatics Center, Peking University, Beijing, China.
  • Zhang ZF; Department of Epidemiology, UCLA Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
  • López-Carrillo L; Mexico National Institute of Public Health, Cuernavaca, Mexico.
  • Lunet N; EPIUnit, Instituto de Saúde Pública da Universidade Do Porto, Porto, Portugal.
  • Morais S; Laboratório Para a Investigação Integrativa E Translacional Em Saúde Populacional (ITR), Porto, Portugal.
  • Zaridze D; Departamento de Ciências da Saúde Pública E Forenses E Educação Médica, Faculdade de Medicina, Universidade Do Porto, Porto, Portugal.
  • Maximovich D; EPIUnit, Instituto de Saúde Pública da Universidade Do Porto, Porto, Portugal.
  • Martín V; Laboratório Para a Investigação Integrativa E Translacional Em Saúde Populacional (ITR), Porto, Portugal.
  • Castano-Vinyals G; Departamento de Ciências da Saúde Pública E Forenses E Educação Médica, Faculdade de Medicina, Universidade Do Porto, Porto, Portugal.
  • Vioque J; Department of Clinical Epidemiology, N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russia.
  • González-Palacios S; Department of Clinical Epidemiology, N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russia.
  • Ward MH; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Malekzadeh R; Instituto de Biomedicina, Universidad de León, León, Spain.
  • Pakseresht M; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Hernández-Ramirez RU; Barcelona Institute for Global Health-ISGlobal, Barcelona, Spain.
  • López-Cervantes M; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Negri E; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Turati F; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Rabkin CS; Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH), Alicante, Spain.
  • Tsugane S; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Hidaka A; Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH), Alicante, Spain.
  • Lagiou A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Lagiou P; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Camargo MC; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Curado MP; Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Canada.
  • Boccia S; Nutritional Epidemiology Group, Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, UK.
  • La Vecchia C; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
  • Boffetta P; Facultad de Medicina, National Autonomous University of Mexico (UNAM), Coyoacán, Mexico.
Gastric Cancer ; 27(3): 461-472, 2024 05.
Article em En | MEDLINE | ID: mdl-38436761
ABSTRACT

BACKGROUND:

Previous studies suggest that dietary vitamin C is inversely associated with gastric cancer (GC), but most of them did not consider intake of fruit and vegetables. Thus, we aimed to evaluate this association within the Stomach cancer Pooling (StoP) Project, a consortium of epidemiological studies on GC.

METHODS:

Fourteen case-control studies were included in the analysis (5362 cases, 11,497 controls). We estimated odds ratios (ORs) and corresponding 95% confidence intervals (CIs) for the association between dietary intake of vitamin C and GC, adjusted for relevant confounders and for intake of fruit and vegetables. The dose-response relationship was evaluated using mixed-effects logistic models with second-order fractional polynomials.

RESULTS:

Individuals in the highest quartile of dietary vitamin C intake had reduced odds of GC compared with those in the lowest quartile (OR 0.64; 95% CI 0.58, 0.72). Additional adjustment for fruit and vegetables intake led to an OR of 0.85 (95% CI 0.73, 0.98). A significant inverse association was observed for noncardia GC, as well as for both intestinal and diffuse types of the disease. The results of the dose-response analysis showed decreasing ORs of GC up to 150-200 mg/day of vitamin C (OR 0.54; 95% CI 0.41, 0.71), whereas ORs for higher intakes were close to 1.0.

CONCLUSIONS:

The findings of our pooled study suggest that vitamin C is inversely associated with GC, with a potentially beneficial effect also for intakes above the currently recommended daily intake (90 mg for men and 75 mg for women).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Ascórbico / Neoplasias Gástricas Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Ascórbico / Neoplasias Gástricas Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article